10577 Results

Congress Abstract

DOSIMETRIC COMPARISON OF BONE MARROW SPARING VMAT VS 3DCRT IN LOCALLY ADVANCED RECTAL CANCER

Authors: LAM , Sze Man(1)[cman.lam93@gmail.com];Lee, Wan Yan Venus(2)*
(1)Prince of Wales Hospital, Department of Clinical Oncology, Hong Kong, Hong Kong SAR China;(2)Tuen Mun Hospital,Hong Kong, Hong Kong SAR China;
Show Affiliations

Journal Article

Beam output checks of a commercial high-field magnetic resonance-guided radiotherapy machine with its on-board megavoltage imager

Authors: Guido C. Hilgers, Marijke Ikink, Ilona Potters, Danny Schuring

Journal Article

Assessment of risk factors associated with development of oronasal fistula as a late complication after carbon-ion radiotherapy for head and neck cancer

Authors: Tapesh Bhattacharyya, Masashi Koto, Hiroaki Ikawa, Kazuhiko Hayashi, Yasuhito Hagiwara, Hiroshi Tsuji

Journal Article

Adaptive magnetic resonance-guided neurovascular-sparing radiotherapy for preservation of erectile function in prostate cancer patients

Authors: Frederik R. Teunissen, Ruud C. Wortel, Jochem Hes, Thomas Willigenburg, Eline N. de Groot-van Breugel, Johannes C.J. de Boer, Harm H.E. van Melick, Helena M. Verkooijen, Jochem R.N. van der Voort van Zyp

Congress Abstract

Evaluation of the Versius surgical system. A new robotic platform in head and neck surgery.

Authors:

Jack Faulkner1, Jean-Pierre Jeannon2, Asit Arora2

1Kings College London, School of Biomedical Engineering and Image Sciences, London, United Kingdom; 2Guy's and St Thomas' NHS Foundation Trust, Head and Neck Surgery, London, United Kingdom

Show Affiliations

Journal Article

Homogeneous and heterogeneous boosting in prostate radiotherapy: Treatment planning and target dosimetry comparison

Authors: Yutong Zhao, Annette Haworth, Scott Williams, Simon Goodall, Ben Hug, Michelle Krawiec, Jonathan Sykes, Jeremy Croker, Jeremy Booth, Andrew Le, Shrikant Deshpande, Richard Walther, Pejman Rowshanfarzad, Martin A. Ebert

Congress Abstract

T2w-MRI with pilocarpine administration for monitoring salivary gland function after irradiation

Authors:

Olga Zlygosteva1, Inga S. Juvkam2, Hilde K. Galtung2, Tine M. Søland2, Nina F. J. Edin1, Eirik Malinen1, Eirik Malinen3

1University of Oslo, Department of Physics, Oslo, Norway; 2University of Oslo, Institute of Oral Biology, Oslo, Norway; 3Oslo University Hospital, Department of Medical Physics, Oslo, Norway

Show Affiliations

Congress Abstract

Salvage LDR Prostate Brachytherapy: Results of NRG/RTOG-0526 Trial for Local Recurrence after EBRT

Authors: Crook|, Juanita(1)[jcrook@bccancer.bc.ca];Rodgers|, Joseph(2);Pisansky|, Thomas(3);Trabulsi|, Edouard(4);Amin|, Mahul(5);Bice|, William(6);Morton|, Gerard(7);Pervez|, Nadeem(8);Vigneault|, Eric(9);Catton|, Charles(10);Michalski|, Jeff(11);Roach|, Mack(12);Beyer|, David(13);Rossi|, Peter(14);Horwitz|, Eric(15);Donavanik|, Viroon(16);Sandler|, Howard(17);
(1)BC Cancer Agency - Southern Interior, Radiation Oncology, Kelowna, Canada;(2)NRG Oncology, Statistics and Data Management Centre, Philadelphoa, USA;(3)Mayo Clinic, Radiation Oncology, Rochester, USA;(4)Thomas Jefferson University Hospital, Urology, Philadelphia, USA;(5)University of Tennessee Health Science Centre, Pathology, Memphis, USA;(6)John Muir Health Systems, Radiation Oncology, Walnut Creek, USA;(7)Sunnybrook Health Sciences Centre- Odette Cancer Centre, Radiation Oncology, Toronto, Canada;(8)Cross Cancer Institute, Radiation Oncology, Edmonton, Canada;(9)Centre Hospitalier Universitaire de Quebec, Radiation Oncology, Quebec, Canada;(10)Princess Margaret Cancer Centre- University Health Network, Radiation Oncology, Toronto, Canada;(11)Washington University School of Medicine, Radiation Oncology, St Louis, USA;(12)Helen Diller Family Comprehensive Cancer Center- University of California, Radiation Oncology, San Francisco, USA;(13)Cancer Centers of Northern Arizona, Radiation Oncology, Sedona, USA;(14)Valley View Hospital Cancer Centre- Emory University, Radiation Oncology, Atlanta, USA;(15)Fox Chase Cancer Center, Radiation Oncology, Philadelphia, USA;(16)Helen F Graham Cancer Center- Christiana Care, Radiation Oncology, Newark, USA;(17)Cedar Sinai, Radiation Oncology, Los Angeles, USA;
Show Affiliations

Congress Abstract

Predicted cardiac and second cancer risks following treatment for Hodgkin lymphoma in Ireland

Authors:

Orla Houlihan1, Georgios Ntentas2,3, David J Cutter4,5, Patricia Daly1,6,7, Charles Gillham8,6,7, Orla McArdle1, Frances K Duane1,6,7

1St Luke's Radiation Oncology Network, Radiation Oncology, Dublin, Ireland; 2Nuffield Department of Population Health, University of Oxford, Medical Physics, Oxford, United Kingdom; 3Guy’s and St Thomas’ NHS Foundation Trust, Medical Physics, London, United Kingdom; 4Nuffield Department of Population Health, University of Oxford, Clinical Oncology, Oxford, United Kingdom; 5Oxford Cancer Centre, Oxford University Hospitals NHS Foundation Trust, Clinical Oncology, Oxford, United Kingdom; 6Trinity St James’s Cancer Institute, St. James’s Hospital, Radiation Oncology, Dublin, Ireland; 7Trinity College Dublin, School of Medicine, Dublin, Ireland; 8St Luke’s Radiation Oncology Network, Radiation Oncology, Dublin, Ireland

Show Affiliations
*:*